Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Chase & Co (JPM) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

JPMorgan Chase & CoTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

JPMorgan Chase & Co vs Relay Therapeutics Inc. Common Stock — how do they compare? JPMorgan Chase & Co trades at $332.56 (market cap $876.09B), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.94B). The key difference: JPMorgan Chase & Co is far larger — about 222.4× Relay Therapeutics Inc. Common Stock's market cap, and JPMorgan Chase & Co pays a 2% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Chase & Co for 127 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

JPMRLAY
Market Cap
$876.09B$3.94B
Volume
6,651,1433,432,928
Sector
FinancialsHealth
52-Week High
$365.18$20.75
52-Week Low
$282.84$6.03
Typical Hold Time
127 Days0 Days
Enterprise Value
$1.81T$3.06B
Dividend Yield
2%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Chase & Co

JPMorgan Chase (JPM) trades at $329.58, down 0.51% on the day, with a bearish technical signal. The stock shows strong fundamentals, with a P/E of 14.12 and net income margin of 33.38%. Recent earnings beat expectations in Q1 and Q2 2026, though Q4 2025 was a miss. Analyst consensus is a Moderate Buy with a $373.18 price target, implying potential upside. Cash flow trends show significant financing activities offsetting negative operating cash flows.

The outlook for JPM is positive based on robust profitability and analyst support, but risks include volatile cash flows, geopolitical tensions affecting banking sectors, and CEO warnings on economic challenges. The stock's current price near support at $327 suggests a potential entry point for long-term investors, though near-term bearish technicals warrant caution.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JPM
80% Buy20% Sell
Avg holding period · 127 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About JPMorgan Chase & Co

JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.

Read more on JPM →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →